Literature DB >> 21475897

Electroporation of RNA stimulates immunity to an encoded reporter gene in mice.

John M Piggott1, Brian J Sheahan, Declan M Soden, Gerald C O'Sullivan, Gregory J Atkins.   

Abstract

Electroporation is the application of high-voltage short-duration pulses to transiently permeabilize cells, permitting the cellular uptake of macromolecules, including nucleic acid. Although much attention has been focused on DNA vaccines, antigen-encoding RNA molecules may also stimulate immunity. Several methods are being examined in an effort to enhance the efficacy of nucleic acid delivery. One such method is the application of electroporation. The present study was designed to develop electroporation for use as a method of RNA delivery in conjunction with the Semliki Forest virus (SFV) RNA vector system for stimulation of immunity. Expression of SFV-based β-galactosidase and luciferase vectors was observed in the muscle after electroporation. Although some tissue damage was induced following intramuscular injection and electroporation with SFV vector RNA encoding LacZ at optimum pulse conditions, immunity to LacZ was efficiently induced. Following two immunizations, there was a higher IgG2a antibody response with the viral vector delivery and a higher IgG1 response in electroporated rSFV-LacZ RNA immunized mice.

Entities:  

Year:  2009        PMID: 21475897     DOI: 10.3892/mmr_00000168

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  10 in total

Review 1.  Advances in Biomaterials for Drug Delivery.

Authors:  Owen S Fenton; Katy N Olafson; Padmini S Pillai; Michael J Mitchell; Robert Langer
Journal:  Adv Mater       Date:  2018-05-07       Impact factor: 30.849

2.  CD8 T-cell priming upon mRNA vaccination is restricted to bone-marrow-derived antigen-presenting cells and may involve antigen transfer from myocytes.

Authors:  Sandra Lazzaro; Cinzia Giovani; Simona Mangiavacchi; Diletta Magini; Domenico Maione; Barbara Baudner; Andrew J Geall; Ennio De Gregorio; Ugo D'Oro; Cecilia Buonsanti
Journal:  Immunology       Date:  2015-08-28       Impact factor: 7.397

3.  Nonviral delivery of self-amplifying RNA vaccines.

Authors:  Andrew J Geall; Ayush Verma; Gillis R Otten; Christine A Shaw; Armin Hekele; Kaustuv Banerjee; Yen Cu; Clayton W Beard; Luis A Brito; Thomas Krucker; Derek T O'Hagan; Manmohan Singh; Peter W Mason; Nicholas M Valiante; Philip R Dormitzer; Susan W Barnett; Rino Rappuoli; Jeffrey B Ulmer; Christian W Mandl
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

Review 4.  mRNA vaccines - a new era in vaccinology.

Authors:  Norbert Pardi; Michael J Hogan; Frederick W Porter; Drew Weissman
Journal:  Nat Rev Drug Discov       Date:  2018-01-12       Impact factor: 84.694

5.  Intradermal electroporation of naked replicon RNA elicits strong immune responses.

Authors:  Daniel X Johansson; Karl Ljungberg; Maria Kakoulidou; Peter Liljeström
Journal:  PLoS One       Date:  2012-01-04       Impact factor: 3.240

6.  Conjugation of Mannans to Enhance the Potency of Liposome Nanoparticles for the Delivery of RNA Vaccines.

Authors:  Roshan Goswami; Derek T O'Hagan; Roberto Adamo; Barbara C Baudner
Journal:  Pharmaceutics       Date:  2021-02-09       Impact factor: 6.321

7.  Self-Amplifying Pestivirus Replicon RNA Encoding Influenza Virus Nucleoprotein and Hemagglutinin Promote Humoral and Cellular Immune Responses in Pigs.

Authors:  Thomas Démoulins; Nicolas Ruggli; Markus Gerber; Lisa J Thomann-Harwood; Thomas Ebensen; Kai Schulze; Carlos A Guzmán; Kenneth C McCullough
Journal:  Front Immunol       Date:  2021-01-28       Impact factor: 7.561

8.  Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in Situ.

Authors:  Yen Cu; Kate E Broderick; Kaustuv Banerjee; Julie Hickman; Gillis Otten; Susan Barnett; Gleb Kichaev; Niranjan Y Sardesai; Jeffrey B Ulmer; Andrew Geall
Journal:  Vaccines (Basel)       Date:  2013-08-22

Review 9.  Development of nucleic acid vaccines: use of self-amplifying RNA in lipid nanoparticles.

Authors:  Alicia Rodríguez-Gascón; Ana del Pozo-Rodríguez; María Ángeles Solinís
Journal:  Int J Nanomedicine       Date:  2014-04-10

Review 10.  A new generation of vaccines based on alphavirus self-amplifying RNA.

Authors:  María Cristina Ballesteros-Briones; Noelia Silva-Pilipich; Guillermo Herrador-Cañete; Lucia Vanrell; Cristian Smerdou
Journal:  Curr Opin Virol       Date:  2020-09-05       Impact factor: 7.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.